文献速递炎症性肠病

炎症性肠病患者加入医疗之家后计划外医疗和疾病活动减少且生活质量提高

Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-04-12

该回顾性分析纳入2015年6月至2016年7月加入炎症性肠病专科医疗之家的322例患者,比较入组前后1年急诊就诊和住院次数,并评估疾病活动度和生活质量变化。结果显示入组后急诊就诊减少47.3%(P<.0001)、住院减少35.9%(P=.008),疾病活动度评分下降且生活质量提高。

要点

  • 加入炎症性肠病专科医疗之家后1年,急诊就诊减少47.3%,住院减少35.9%。
  • 入组后中位Harvey-Bradshaw指数从4降至3.5,溃疡性结肠炎活动指数从4降至3。
  • 入组时使用糖皮质激素或阿片类药物及低生活质量与持续急诊就诊和住院相关。

核心结论

  • 建立炎症性肠病专科医疗之家可行,入组后1年显著减少计划外医疗和疾病活动并提高患者生活质量。

研究设计与样本

  • 回顾性分析纳入2015年6月至2016年7月与匹兹堡大学医学中心健康计划合作加入炎症性肠病专科医疗之家的322例患者,女性占58%,平均年龄34.6岁,克罗恩病占62%,既往炎症性肠病手术占32%,随访至少1年。

主要发现

  • 与入组前1年相比,入组后急诊就诊减少47.3%(P<.0001),住院减少35.9%(P=.008)。
  • 入组后1年中位Harvey-Bradshaw指数从4降至3.5(P=.002),中位溃疡性结肠炎活动指数从4降至3(P=.0003)。
  • 入组后1年中位短炎症性肠病问卷评分从50升至51.8(P<.0001)。
  • 基线评分处于最高和最低四分位数的患者改善最明显。
  • 多变量回归分析显示,入组时使用糖皮质激素(OR 2.72;95%CI 1.32-5.66;P=.007)或阿片类药物(OR 3.20;95%CI 1.32-7.78;P=.01)及低生活质量(OR 4.44;95%CI 1.08-18.250;P=.04)与持续急诊就诊和住院显著相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Specialty medical homes (SMHs) are a new health care model in which a multidisciplinary team and specialists manage patients with chronic diseases. As part of a large integrated payer-provider network, we formed an inflammatory bowel diseases (IBDs) SMH and investigated its effects on health care use, disease activity, and quality of life (QoL). METHODS: We performed a retrospective analysis of 322 patients (58% female; mean age, 34.6 y; 62% with Crohn's disease; 32% with prior IBD surgery) enrolled in an IBD SMH, in conjunction with the University of Pittsburgh Medical Center Health Plan, from June 2015 through July 2016. Patients had at least 1 year of follow up. We evaluated changes in numbers of emergency department visits and hospitalizations from the year before vs after SMH enrollment. Secondary measures included IBD activity assessments and QoL. RESULTS: Compared to the year before IBD SMH enrollment, patients had a 47.3% reduction in emergency department visits (P < .0001) and a 35.9% reduction in hospitalizations (P = .008). In the year following IBD SMH enrollment, patients had significant reductions in the median Harvey-Bradshaw Index score (reduced from 4 to 3.5; P = .002), and median ulcerative colitis activity index score (from 4 to 3; P = .0003), and increases in QoL (median short inflammatory bowel disease questionnaire score increased from 50 to 51.8; P < .0001). Patients in the most extreme (highest and lowest) quartiles had the most improvement when we compared scores at baseline vs after enrollment. Based on multivariable regression analysis, use of corticosteroids (odds ratio [OR], 2.72; 95% CI, 1.32-5.66; P = .007) or opioids (OR, 3.20; 95% CI, 1.32-7.78; P = .01), and low QoL (OR, 4.44; 95% CI, 1.08-18.250; P = .04) at enrollment were significantly associated with persistent emergency department visits and hospitalizations. CONCLUSIONS: We found development of an IBD SMH to be feasible and significantly reduce unplanned care and disease activity and increase patient QoL 1 year after enrollment.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Regueiro M, Click B, Anderson A, et al. Reduced Unplanned Care and Disease Activity and Increased Quality of Life After Patient Enrollment in an Inflammatory Bowel Disease Medical Home. Clin Gastroenterol Hepatol. 2018. PMID: 29654918. doi:10.1016/j.cgh.2018.04.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。